“National Clearinghouse” To Guide Selection, Testing, Evaluating Of Suspected Carcinogens
In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays
NCI To Seek Cancer Act Changes On Center Grant Limits
NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita
Diet-Nutrition Grant Guidelines: NIH Says They’re CREGS, Gori Says They’re Not
Research Triangles Lands Plant Drug Contract Renewal
RFPs Go Out To Cooperative Groups for Community Programs
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
